| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233932 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 5 Pages |
Abstract
In a cohort of patients treated with adjuvant 5-FU-based CRT at the Johns Hopkins Hospital, having a VR at the time of PD resulted in similar complication rates and survival. These data support the feasibility and safety of adjuvant CRT in patients undergoing VR at the time of PD.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Boris M.D., Sushanth Ph.D., Steven H. M.D., Ph.D., John L. M.D., Timothy M. M.D., Ralph H. M.D., Michael J. M.D., Barish H. M.D., Clinton M.D., Christopher L. M.D., Ph.D., Joseph M. M.D., M.Sc.,